In modern pharmaceutical production, analytics is the foundation of quality. This is why our control strategy is built around two key methods: HPLC and mass spectrometry. Together, they allow us to assess purity, verify the structure of the active substance, and identify any deviations long before a batch is released. This article explains how these methods work and why we use them together.
HPLC: the method that verifies purity
High-performance liquid chromatography (HPLC) is the primary tool for evaluating the quantitative and qualitative composition of a substance. It separates all components of a sample and shows exactly what it contains: the active ingredient, impurities, solvent residues, and degradation products.
With HPLC we can:
- determine the exact percentage of active ingredient in every batch;
- detect even trace impurities;
- monitor the stability of a substance over time;
- confirm compliance with pharmacopoeial specifications.
HPLC is used by regulators around the world as a standard quality control method. Whenever purity needs to be assessed, this is the technique we start with.
Mass spectrometry: confirmation of structural authenticity
If HPLC is responsible for purity, mass spectrometry (MS) is responsible for identity. It determines the exact molecular mass, structure, and fragmentation pattern of a compound, confirming that the molecule present in the product is truly the one intended.
Mass spectrometry allows us to:
- verify that the structure of the active ingredient matches the reference;
- distinguish authentic recombinant proteins or peptides from similar molecules;
- detect impurities invisible to conventional analytical methods;
- ensure that the substance contains no unexpected biological fragments.
For the market, this is critical: the authenticity of a molecule of, for example TNT-400 (Blend), is a key indicator of safety and effectiveness.
Why HPLC and mass spectrometry only work fully when used together
The two methods do not replace each other; they address different tasks.
- HPLC reveals purity, the percentage of active substance, and impurity profiles.
- MS reveals structure, origin, and molecular identity.
When data from both techniques are combined, we obtain a complete quality picture: the substance is both pure and correctly identified. This is exactly what pharmacopoeias, GMP systems, and regulators require. It is also what distributors expect when they need batch-to-batch predictability.
How we use HPLC and MS in our QA process
We apply both methods at several stages, from raw material assessment to final batch release. Our approach includes:
- raw material analysis: verifying purity and confirming the structure and origin of the substance;
- in-process control: monitoring degradation and by-product;
- final batch testing: confirming identity, purity, impurity levels, and stability;
- comparison with reference standards: ensuring compliance with pharmacopoeial specifications;
- documentation within GMP systems: guaranteeing traceability and immutability of analytical records.
This process allows us to release substances with fully confirmed structure, purity, and stability. For partners, this means one thing: every batch is based on data, not assumptions.
Conclusion
HPLC shows purity; mass spectrometry shows structure. Together, they provide a complete and documented understanding of each batch’s quality. We use both methods at every stage of raw material and finished product testing, ensuring that distributors receive predictable, verifiable analytical results. This turns quality from a promise into a proven fact.
If you’re looking to expand your portfolio with high-quality, fully compliant pharmaceutical products, we invite you to partner with us as a distributor. Our verified processes and consistent purity standards ensure reliability you can trust. Let’s build a strong partnership based on quality and transparency.